Exact Sciences schedules third quarter 2021 earnings call
Exact Sciences Corp. (Nasdaq: EXAS) will release its third quarter 2021 financial results on November 2, 2021, after U.S. market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Exact Sciences Corp. (Nasdaq: EXAS) will release its third quarter 2021 financial results on November 2, 2021, after U.S. market close. A conference call to discuss these results will follow at 5 p.m. ET. The webcast will be accessible via the company's website. This follows the company's focus on developing cancer screening and diagnostic tests, including Cologuard and Oncotype tests. Exact Sciences continues to invest in its product pipeline to enhance support for cancer diagnosis and treatment.
Positive
- Investment in product pipeline supports enhanced cancer diagnosis and treatment.
Negative
- None.
Details
News Market Reaction – EXAS
The recorded move for EXAS in the trading session of this news was -1.90%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MADISON, Wis., Oct. 8, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its third quarter 2021 financial results after the close of the U.S. financial markets on November 2, 2021. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.
Third quarter 2021 webcast & conference call details
Date: Tuesday, November 2, 2021
Time: 5 p.m. ET
Webcast: The live webcast can be accessed at www.exactsciences.com
Telephone: Domestic callers, dial 833-952-1519
International callers, dial +1 236-714-2125
Access code for both domestic and international callers: 2782364
An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-585-8367 domestically or 416-621-4642 internationally. The access code for the replay of the call is 2782364. The webcast, conference call and replay are open to all interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter answers to give people the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype tests, Exact Sciences is investing in its product pipeline to support patients throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815
View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-schedules-third-quarter-2021-earnings-call-301395879.html
SOURCE Exact Sciences Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.